Cargando…
A Case Series of Refractory Cutaneous Sarcoidosis Successfully Treated with Infliximab
INTRODUCTION: Sarcoidosis is a systemic granulomatous disease of unknown cause. The management of sarcoidosis remains problematic. Systemic and topical corticosteroids are the mainstay of therapy but may cause unacceptable side effects. Biologic therapies, such as infliximab, have recently been prop...
Autores principales: | Tuchinda, Papapit, Bremmer, Matthew, Gaspari, Anthony A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare Communications
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510393/ https://www.ncbi.nlm.nih.gov/pubmed/23205333 http://dx.doi.org/10.1007/s13555-012-0011-9 |
Ejemplares similares
-
Pediatric Gastrointestinal Sarcoidosis: Successful Treatment with Infliximab
por: Alawdah, Laila, et al.
Publicado: (2016) -
Simultaneous development of sarcoidosis and cutaneous vasculitis in a patient with refractory Crohn’s disease during infliximab therapy
por: Numakura, Tadahisa, et al.
Publicado: (2016) -
Refractory Duodenal Crohn's Disease Successfully Treated with Infliximab
por: Kim, You Lim, et al.
Publicado: (2014) -
Infliximab Treatment of Refractory Cardiac Sarcoidosis
por: Asawaeer, Majid, et al.
Publicado: (2020) -
Pyoderma gangrenosum associated with chronic refractory pouchitis: a case successfully treated with infliximab
por: Koumaki, Dimitra, et al.
Publicado: (2020)